(4R,5S)-2-(6-Benzhydrylpyridin-2-yl)-4,5-diphenyl-4,5-dihydrooxazole, 97%, 1g

2-(3-(ETHOXYCARBONYL)-4-METHYL-1H-PYRAZOL-1-YL)BENZOIC ACID, 90.0%, 500mg

Atopaxar, 98.05%, 10mg

1,4-oxazepan-5-one, 98.0%, 5g

(5-Bromo-3-(trifluoromethyl)pyridin-2-yl)methanol, 95.0%, 50mg

N-(4-Iodophenyl)acetamide, 95.0%, 100g

bScope BS.1153-EPLPH for phase contrast. Triocular with HWF 10x/20 mm eyepieces and Quadruple revolver E-plan Phase 10/20/S40 S100x

3-Chloro-2-fluoro-4-(trifluoromethyl)pyridine, 98+%, 100mg

Methyl 1,2,3,4-tetrahydroquinoline-7-carboxylate hydrochloride, 95.0%, 100mg

5-(Benzyloxy)-2-hydroxybenzoic acid, 95.0%, 250mg

2-METHYL-2H-INDAZOLE-5-CARBOXYLIC ACID, 95.0%, 10g

7-Methyl-3,4-dihydroisoquinolin-1(2H)-one, 95.0%, 5g

2,5-Difluoro-3-nitrobenzoic acid, 95.0%, 100mg